Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study of the Diagnostic Accuracy and Feasibility of the Xpert Ultra for Detection of TB and Rifampin Resistance in Adults Suspected of Having Pulmonary TB

NCT03072576 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT03072576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study of the Diagnostic Accuracy and Feasibility of the Xpert Ultra for Detection of TB and Rifampin Resistance in Adults Suspected of Having Pulmonary TB
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
October 31, 2017
Enrollment
1,400 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary